← Back to Analyst Consensus 
VXRT Buy
Vaxart, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 27, 2025 | B. Riley Securities | maintain | Buy → Buy | $2 | 54% |
| Aug 15, 2024 | Oppenheimer | initiate | — → Outperform | $4 | 52% |
| Jan 31, 2024 | B. Riley Securities | upgrade | Neutral → Buy | $2 | 54% |
| Sep 7, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $4 | 50% |
| Aug 7, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $4 | 50% |
| Dec 19, 2022 | B. Riley Securities | maintain | — → Neutral | $1.5 | 54% |
| Sep 2, 2022 | Cantor Fitzgerald | maintain | — → Overweight | $8 | 50% |
| May 19, 2022 | B. Riley Securities | maintain | — → Neutral | $6 | 54% |
| Nov 2, 2021 | Cantor Fitzgerald | initiate | — → Overweight | $15 | 50% |
| Jun 30, 2021 | B. Riley Securities | downgrade | Buy → Neutral | $9 | 54% |
| Jun 24, 2021 | Jefferies | initiate | — → Buy | $13 | 52% |
| Jun 11, 2021 | Piper Sandler | initiate | — → Overweight | $18 | 54% |
| Aug 12, 2020 | HC Wainwright & Co. | maintain | — → Buy | $17 | 44% |
| Jul 13, 2020 | B. Riley Securities | initiate | — → Buy | $22 | 54% |
| Apr 30, 2020 | HC Wainwright & Co. | reiterate | — → Buy | $7 | 44% |
| Jun 27, 2019 | HC Wainwright & Co. | initiate | — → Buy | $2 | 44% |
Price Target Trend
May 7, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days